Disease-Specific Research meetings & conferences

14th International Congress on Schizophrenia Research

Sunday 21 through Thursday 25 April 2013 Orlando, Florida. Satellite Meetings will be held Saturday 20 and Sunday 21 April 2013.

Society for Immunotherapy of Cancer 27th Annual Meeting

October 26-28, 2012 North Bethesda, Maryland

The SITC 27th Annual Meeting allows for scientific exchange of the most cutting-edge preclinical and clinical data on immunotherapies and biological therapy of cancer. The program included dynamic presentations, interactive panel discussions and scientific posters on the most timely topics in cancer immunotherapy as well as vital information on clinical trial design and regulatory issues to advance collaboration and translation of cancer immunotherapies.

SITC is ideally positioned to meet the identified needs of our attendees. SITC’s strength lies in its history of organizing successful scientific conferences that gather clinicians and scientists from around the globe to interact and discuss the most important issues in cancer immunotherapy. By addressing these needs, SITC advances effective, efficient research and interaction on promising cancer therapies with biological and immunological agents. Through its integrated programs, SITC promotes productive collaboration among scientists and with other organizations in the field. Ultimately this scientific exchange and collaborative environment will lead to better cancer patient outcomes with novel cancer immunotherapies.

The SITC 27th Annual Meeting program format and content is designed to address identified needs/practice gaps and promotes:

Exchange between basic and clinical researchers, thus improving the caliber of the science and promoting translation
Discussion on potential hurdles in cancer immunotherapy from the trial design and regulatory perspective
Integrated understanding of the state of cancer immunotherapy research in today’s environment, identification of potential funding opportunities, and mentoring of junior investigators
Discussion of novel therapies and applications based on the research presented
Interactions with industry to promote access to novel agents for clinical development

Intended Audience

The audience for this program is basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, postdoctoral fellows, and allied health professionals involved in cancer research.

Program Goals

Exchange information on the most recent advances in tumor immunology and cancer immunotherapy
Convey recent advances in biology and immunotherapy as they relate to specific cancers and various immunotherapy modalities, cell subsets, animal models, and aspects of negative regulation in the tumor microenvironment
Identify promising research opportunities, new techniques and clinical applications incorporating these advances
Establish dialogue between academia, industry and government on these advances

Expected Learner Outcomes

Upon completion of this program, the participants will be able to:

Summarize the most recent advances in tumor immunology and cancer immunotherapy
Integrate recent advances in cancer immunology and immunotherapy into basic, clinical and translational research
Incorporate new research and techniques into clinical applications for cancer immunotherapy
Establish and solidify collaborations among the various members of academia, industry, government and clinical practices to promote clinical evaluation of these advances in more efficient trials

National Hemophilia Foundation 64th Annual Meeting

 “Mapping Our Future”

November 8-10, 2012 Orlando, Florida

7th International Pediatric Intestinal Failure and Rehabilitation Symposium

September 6-8, 2012 Pittsburgh, Pennsylvania

Get ready for the 7th International Pediatric Intestinal Failure and Rehabilitation Symposium (PIFRS), September 6 - 8, 2012 in Pittsburgh, Pennsylvania.

This three-day course will focus on new discoveries and developments concerning the etiology, pathophysiology, surgical and nonsurgical therapies and outcomes-based research for intestinal failure in children. Focus areas will include the latest in medical therapies for intestinal failure, improving outcomes through multidisciplinary intestinal rehabilitation programs, and the latest in pediatric intestinal transplantation.

Who Should Attend:

The symposium is designed for pediatricians, neonatologists, transplant surgeons, gastroenterologists, pediatric surgeons, family practice physicians, nurses, dietitians, mid-level providers and parents/guardians who care for children with short bowel syndrome and small bowel intestinal transplants. All other health professionals are also welcome.

Questions? Please contact sharon.mastro@chp.edu.

90th Annual Meeting of the American Academy of Optometry

October 24-27, 2012 Phoenix, Arizona

Academy 2012 Phoenix will be the optometry and vision science event of the year.

Come join us for scientific sessions that represent the continuing education of the future, education taught by leading clinicians and researchers, papers and posters on state-of-theart practices, and enjoyable social events where you can let loose and catch up with your friends and colleagues.

The Academy’s Annual Meeting provides a diverse array of groundbreaking research in optometry and vision science and relevant education on the latest practices. Come explore all that Academy 2012 Phoenix has to offer. You can choose from over 250 hours of lectures & workshops, eight Section and Special Interest Group symposia, hundreds of scientific papers and posters, and exciting social events. The plenary session is, “Today’s Research, Tomorrow’s Practice: Autism Spectrum Disorders.” The presentation will help you understand the current research on autism and how to differentiate fact versus fiction.

The Monroe J. Hirsch Research Symposium, co-sponsored by our Academy’s Research Committee and the Low Vision Section, “Not Your Grandmother’s Macular Degeneration: Current Issues in AMD,” will focus on age-related macular degeneration and changes in our related knowledge over the last 15 years, improving our knowledge of etiology, genetics, and treatments for AMD.

12th International Symposium on Myelodysplastic Syndromes

May 8-11, 2013 Berlin, Germany

The scientific program is designed to meet the aims of The MDS Foundation, which are “to provide an ongoing exchange of information relating to MDS and provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to both physicians and patients." The format will include plenary sessions (including a nursing symposium), debates, case-based discussion, topical workshops, oral and poster presentations.

This 12th symposium will again promote the clinical application of existing knowledge and the acquisition of new knowledge by bringing together clinicians, scientists and educators from around the world who deal with MDS.

Clinical Management: General
Diagnosis (including morphology, flow cytometry, molecular)
Epidemiology (including demographics, quality of life, co-morbidity)
Pathogenesis (including molecular, immunological, cellular, animal models, other)
Childhood MDS
Prognostic Factors and Models
Supportive Care including Iron Chelation Therapy
Stem Cell Transplantation
Therapy (including high-risk MDS, low-risk MDS, other)
Other

Joint Meeting of the American Pancreatic Association and the International Association of Pancreatology

October 31 - November 3, 2012 Miami, Florida

The 2012 Annual Meeting of the American Pancreatic Association (APA) to be held jointly with the International Association of Pancreatology (IAP) will take place at the Eden Roc Renaissance in Miami Beach FL from Oct 31-Nov 3. The meeting will include several mini-symposia in addition to abstract driven sessions including a symposia on Pancreatic Stem Cells and Stellate Cells (organized by Minoti Apte and Diane Simeone on Saturday Nov 3) and a consensus conference open to all participants to update the 2002 IAP Evidence-Based Guidelines on the Management of Acute Pancreatitis (on Wednesday October 31).

Recent Advances in the Diagnosis and Treatment of Children's Sleep Disorders

20th June 2012 London, United Kingdom

A full day conference presenting an update on advances in the field of children's sleep disorders. Leading experts in the field of children's sleep medicine will provide an analysis of the latest developments in clinical practice and research.

The aim of this conference is to provide an in-depth understanding of the nature and causes of children's sleep disorders and special considerations for diagnosis and management.

Target Audience
Paediatricians and GPs, Trainees, Paediatric Neurologists, Paediatric Neuroscientists, Child Psychiatrists, Clinical Child Psychologists, Learning Disability Services, Paediatric Researchers, Paediatric Respiratory Clinicians, other Child Healthcare Professionals with an interest in children's sleep disorders.

Topics will include

Childhood obstructive sleep apnoea

Sleep disorders in children with Down syndrome.

Sudden infant death syndrome

Sleeplessness in children with autism

Epilepsy and sleep

Insomnia and excessive sleepiness in adolescents

Treatment options for children's sleep disorders

Plenary sessions will be interspersed with questions and answer sessions and panel discussions. The meeting represents a valuable opportunity to network, share knowledge and ideas, and consider collaborative projects.

Learning Objectives

Describe normal sleep patterns and physiology

Discuss the latest diagnostic assessments and treatments for various children's sleep disorders

Explore the co-occurrence of childhood anxiety and depression and sleep disturbance

Describe the different types of sleep problems presented in children with autism or Down syndrome

Describe the relationships between epilepsy and sleep

Identify the clinical features and differential diagnosis of sleep-related breathing disorders

Discuss the recent views about sudden infant death syndrome

Identify the indications for using medication in the treatment of children's sleep disorders

Contact Us

Conferences & Congresses LTD.
Trading as MEDINEO
165 Spyrou Araouzou
Lordos Water Front Court
Office 502
3036 Limassol
Cyprus

Phone: +357 25 878 844
Fax: +44 870 330 5859

International Federation for Information Processing/International Medical Informatics Association International Working Conference on Interfacing Bio- and Medical Informatics

27 September 2012 Amsterdam, the Netherlands

From 24 to 26 September 2012 the International Federation for Information Processing (IFIP) is having its World Computer Congress WCC2012 in Amsterdam, the Netherlands (www.wcc-2012.org). During the WCC2010 conference in Brisbane, Australia, IFIP and the International Medical Informatics Association (IMIA) organized a joint conference for the first time in their history. Also this time a joint one-day associated meeting will be held on Thursday 27 September. The topic of this meeting will be the link between bioinformatics and medical informatics. IFIP’s Working Groups 5.13 Bioinformatics and its applications and IMIA’s Working Group on Informatics in Genomic Medicine (IGM) are working in this area and supporting this event.

Contact
Prof.dr. Arie Hasman e-mail: a.hasman@amc.uva.nl

Conference topics

Applications:

Personalized medicine

Cancer informatics

Population genetics

Bioinformatics approaches for diseases study

Genomics and proteomics in medicine

Analysis of gene expression, mutation, variations and next generation sequencing

Linking genotype with phenotype

Tools:

Databases, data management and integration

Query languages, information retrieval, interoperability, biomedical ontologies and semantics

Knowledge discovery, machine learning, pattern recognition and text mining

Data visualization

High-performance, grid and cloud computing

14th MS Nurse Workshop

October 9, 2012 Lyon, France

Aim of the course

This is an educational program created to encourage the dissemination of scientific knowledge among nurses working in the field of multiple sclerosis (MS). Disease management in research and clinical practice, with a special emphasis on the nurses’ crucial role, will be reviewed. Management of main signs and symptoms of the disease, such as spasticity, pain, psychosocial distress, cognitive impairment and genitourinary problems will be addressed both from the physician and nurse perspective.

Learning objectives

This course will offer to participants:

Updates on etiologic factors and pathogenetic mechanisms
An overview of diagnostic tools used in patient screening and follow-up
A review of research methodology in MS
Criteria to optimize treatment administration

Target audience

Nurses involved in the treatment of persons with multiple sclerosis.

Scientific Secretariat

Serono Symposia International Foundation
Salita di San Nicola da Tolentino, 1/b
00187 Rome, Italy

Project manager: Serena Dell’Ariccia
T +39-06-420 413 251 | F +39-06-420 413 677
E-mail: info@seronosymposia.org

Serono Symposia International Foundation is a Swiss Foundation with headquarters in 14, rue du Rhône, 1204 Geneva, Switzerland